Literature DB >> 12883706

Rho regulates the hepatocyte growth factor/scatter factor-stimulated cell motility of human oral squamous cell carcinoma cells.

Hiroyuki Kitajo1, Toshiyuki Shibata, Hiroki Nagayasu, Takashi Kawano, Jun-Ichi Hamada, Tomomi Yamashita, Makoto Arisue.   

Abstract

To investigate the effects of hepatocyte growth factor/scatter factor (HGF/SF) on the invasion and metastasis of human oral squamous cell carcinoma (SCC) cells, we examined cell motility and intercellular signal transduction of a human oral SCC cell line (SAS) obtained from the primary lesion of a tongue carcinoma. HGF/SF stimulation significantly enhanced the motility of SAS cells in a dose-dependent manner. Clostridium botulinum C3 exoenzyme (C3), which is known to selectively impair the function of Ras-related small G-protein p21rho (Rho), significantly reduced the motility of SAS cells. HGF/SF stimulation also enhanced the tyrosine phosphorylation of HGF receptors (c-Met) and focal adhesion kinase (FAK) on SAS cells, but C3 completely inhibited the phosphorylation of FAK. Furthermore, it was observed that Rho A protein, normally located around the nuclear area, was translocated to the membrane and levels in the cytolysate increased following HGF/SF stimulation with no change in Rho A mRNA. These results suggest that the activation of FAK caused by phosphorylation of c-Met may mediate the HGF/SF-induced motility of human oral SCC cells, and that Rho protein regulates the tyrosine phosphorylation of FAK through translocation from the nucleus to the membrane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883706

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

Review 1.  Focal adhesion kinase as a cancer therapy target.

Authors:  Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

2.  HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer.

Authors:  Mukaddes Gumustekin; Aydanur Kargi; Gulay Bulut; Aysim Gozukizil; Cagnur Ulukus; Ilhan Oztop; Nese Atabey
Journal:  Pathol Oncol Res       Date:  2011-07-21       Impact factor: 3.201

3.  Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma.

Authors:  Yiru Xu; Jin Zhou; Thomas E Carey; Jonathan B McHugh; John J Voorhees; Gary J Fisher
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

4.  Serine 34 phosphorylation of rho guanine dissociation inhibitor (RhoGDIalpha) links signaling from conventional protein kinase C to RhoGTPase in cell adhesion.

Authors:  Athanassios Dovas; Youngsil Choi; Atsuko Yoneda; Hinke A B Multhaupt; Seung-Hae Kwon; Dongmin Kang; Eok-Soo Oh; John R Couchman
Journal:  J Biol Chem       Date:  2010-05-15       Impact factor: 5.157

5.  Hepatocyte growth factor (HGF) signals through SHP2 to regulate primary mouse myoblast proliferation.

Authors:  Ju Li; Sarah A Reed; Sally E Johnson
Journal:  Exp Cell Res       Date:  2009-04-23       Impact factor: 3.905

6.  Role of met axis in head and neck cancer.

Authors:  Yiru Xu; Gary J Fisher
Journal:  Cancers (Basel)       Date:  2013-11-26       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.